DRDO Developed '2-DG' Drug Inhibits Coronavirus Multiplication, Likely To Work Against All COVID Variants: Study
DRDO To Transfer Technology Of Anti-COVID Drug '2-DG' To India Pharma Firms, Invites EoI
Reliance Submits Proposal For Use Of Niclosamide As Potential COVID-19 Drug
DRDO’s 2-DG: Anti-Covid Drug Approved By DCGI Was First Studied By Patanjali Researchers
Once Given To Trump, This Antibody Drug Cocktail Receives Emergency Approval To Treat Covid-19 In India
